GHO Capital Leads Consortium to Acquire Majority Stake in Envision Pharma Group from Ardian
November 5, 2020
GHO Capital Partners, leading a consortium that includes Mubadala Investment Company, HarbourVest Partners and Northwestern Mutual, together with Envision management and employees, has acquired a majority stake in Envision Pharma Group as Ardian exits its investment. The transaction will support Envision's continued growth, wider rollout of its iEnvision medical affairs platform and strategic acquisitions to expand its medical affairs, communications and technology capabilities.
- Buyers
- GHO Capital Partners LLP, Mubadala Investment Company, HarbourVest Partners, Northwestern Mutual, Envision management and employees
- Targets
- Envision Pharma Group
- Sellers
- Ardian
- Industry
- Healthcare Services
- Location
- United Kingdom
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Envision Pharma Group Acquires 90TEN
April 8, 2020
Healthcare Services
Envision Pharma Group, a portfolio company backed by Ardian and GHO Capital, has acquired London-based healthcare communications consultancy 90TEN. 90TEN will retain its brand and management, bringing behavioral science-led communications capabilities to Envision's global medical affairs and communications offerings.
-
GHO Capital and Partners Group Invest in Sterling Pharma Solutions
May 25, 2023
Pharmaceuticals
GHO Capital (majority owner) and Partners Group have completed an investment into GHO portfolio company Sterling Pharma Solutions, with Partners Group acquiring a significant minority stake. The transaction is supported by a consortium led by funds managed by AlpInvest Partners and Pantheon and will fund Sterling's expansion of production capacity, capability build-out and further strategic acquisitions across the UK, Europe and the US.
-
Envision Pharma Group Acquires doDOC
March 22, 2021
Software
Envision Pharma Group, a portfolio company of GHO Capital Partners, has acquired doDOC Corp., a Boston-founded SaaS platform for collaborative document review and authoring tailored to the life sciences. doDOC will operate as a business unit under its existing brand and be integrated into Envision's iEnvision medical affairs platform to expand document collaboration capabilities and improve workflow efficiency.
-
GHO Capital Acquires Majority Stake in Sterling Pharma Solutions
February 28, 2019
Pharmaceuticals
GHO Capital has acquired a majority stake in Sterling Pharma Solutions alongside management. The investment will support Sterling's international expansion and accelerate growth of its specialist API development and GMP manufacturing capabilities from its UK base in Newcastle upon Tyne.
-
Envision Pharma Group Acquires Two Labs
November 12, 2020
Healthcare Services
Envision Pharma Group has acquired Two Labs, a Powell, Ohio-based provider of pharmaceutical commercialization, launch planning, market access and market intelligence services. The deal, which follows increased investment in Envision from GHO Capital, strengthens Envision's US presence and expands its launch-excellence capabilities; Excellere Partners will exit its investment in Two Labs.
-
GHO Capital Recapitalizes ClearView Healthcare Partners
September 1, 2021
Healthcare Services
GHO Capital Partners LLP has acquired a majority ownership position in ClearView Healthcare Partners in a majority recapitalisation from RLH Equity Partners and ClearView management. The investment will support ClearView’s international expansion (particularly into Europe) and the broadening of its life-sciences consulting capabilities, including data analytics and pricing & market access services.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.